Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 19 of 19
- JAMP-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsuleHealth CanadaProduct quality
- QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)Health CanadaProduct quality
- MXBBB recalls UMARY ACID HYALURONICFDACGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and…
- Curium US, LLC recalls Kit for the Preparation of Technetium Tc 99m Sestamibi InjectionFDALack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
- Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
- RemedyRepack Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
- PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USPFDACGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
- Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsFDACGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
- Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules and 1 moreFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.